Validation of the Polish version of P-QoL questionnaire

Objective: Pelvic organ prolapse (POP) is a common morbidity that affects many women and significantly decreases quality of life. The severity and the impact of the prolapse on the quality of life are important parameters in the management and follow-up of affected patients. The aim of this validation study was to validate the Polish version of the Prolapse Quality of Life questionnaire (P-QoL). Material and methods: The P-QOL questionnaire was translated into Polish and administered to women recruited from two gynecological outpatient clinics (n = 231). Both symptomatic and asymptomatic women were included in the study and examined in supine position using the Pelvic Organ Prolapse Quantification System (POP-Q). The validity was assessed by comparing symptom scores and quality-of-life scores between symptomatic and asymptomatic women. Results: A total number of 154 symptomatic and 77 asymptomatic women were included. There was a strong correlation between severity of the disease based on physical findings (POP-Q scale) and the P-QoL scores in main prolapse quality-of-life domains. The overall scores for each life domain were significantly different between symptomatic and asymptomatic women (p < 0.001). All the questions regarding symptoms showed significant differences (p < 0.001) between both groups. Conclusions: The Polish version of P-QoL is a valid, reliable, and easily comprehensible instrument to assess quality of life and symptoms in Polish-speaking women suffering from urogenital prolapse

Associations between physical activity and stress levels in medical doctors working in New Zealand and Australia during initial COVID-19 restrictions

In 2020, the world was gripped by the COVID-19 pandemic which put an unprecedented strain on health care workers. The aim of this study was to assess the effects of the Australian and New Zealand lockdowns on physical activity, depression, and anxiety in medical doctors. We hypothesized that during stressful times such as the COVID-19 pandemic lockdown, physical activity would have a positive effect on the mental health of medical doctors. Convenience sampling (using mass emailing via professional networks including medical associations) and snowball sampling were used during the early period of COVID-19 government mandated restrictions (25 March to 27 April 2020) in New Zealand and Australia. All registered medical doctors working in New Zealand and Australia were eligible to participate in the survey. The short survey collected information demographics, levels of physical activity and mental health using the International Physical Activity Questionnaire: Short Form and the Depression, Anxiety and Stress Scale-42. Of 469 participants who completed the survey, over 81% met the recommended physical activity levels (150 minutes of at least moderate-intensity physical activity/week). Physically inactive New Zealand and Australian medical doctors reported significantly higher depression (p = 0.006), anxiety (p = 0.008) and stress (p = 0.002) scores compared to their active counterparts. This study demonstrated that less physical activity was associated with higher anxiety and depression in medical doctors. A key recommendation from this study is to incorporate greater access to physical activity in healthcare settings for medical doctors

Onset of action of the beta 3-adrenoceptor agonist, mirabegron, in Phase II and III clinical trials in patients with overactive bladder

Purpose Long-term persistence with pharmacotherapy for overactive bladder (OAB) requires a drug with an early onset of action and good efficacy and tolerability profile. Although antimuscarinics improve OAB symptoms within 1–2 weeks of initiating treatment, adherence after 3 months is relatively poor due to bothersome side effects (e.g., dry mouth and constipation). Mirabegron, a b3-adrenoceptor agonist, has demonstrated significant improvements in key symptoms of OAB and good tolerability after 12 weeks in Phase III studies. Methods This was a prespecified pooled analysis of three randomized, double-blind, placebo-controlled, 12-week studies, and a Phase II study, to evaluate efficacy and tolerability of mirabegron 25 and 50 mg versus placebo. The main efficacy endpoints were change from baseline to week 1 (Phase II only), week 4, and final visit in mean number of incontinence episodes/24 h, micturitions/24 h, and mean volume voided/micturition (MVV). Results A significant benefit for mirabegron 25 and 50 mg versus placebo was evident at the first assessment point, 4 weeks after initiation of therapy, in Phase III studies for incontinence, micturitions, and MVV. The earliest measured benefit was after 1 week, in the Phase II study. Quality-of-life parameters also significantly improved with mirabegron 25 and 50 mg as early as week 4. Significant benefits continued throughout the studies. Mirabegron was well tolerated. Conclusions The early onset of action and good overall efficacy and tolerability balance that mirabegron offers may lead to high rates of persistence with mirabegron in the long-term treatment of OAB

Strong Lensing Model of SPT-CLJ0356-5337, a Major Merger Candidate at Redshift 1.0359

We present an analysis of the mass distribution inferred from strong lensing by SPT-CL J0356-5337, a cluster of galaxies at redshift z = 1.0359 revealed in the follow-up of the SPT-SZ clusters. The cluster has an Einstein radius of Erad=14 for a source at z = 3 and a mass within 500 kpc of M_500kpc = 4.0+-0.8x10^14Msol. Our spectroscopic identification of three multiply-imaged systems (z = 2.363, z = 2.364, and z = 3.048), combined with HST F606W-band imaging allows us to build a strong lensing model for this cluster with an rms of <0.3'' between the predicted and measured positions of the multiple images. Our modeling reveals a two-component mass distribution in the cluster. One mass component is dominated by the brightest cluster galaxy and the other component, separated by ~170 kpc, contains a group of eight red elliptical galaxies confined in a ~9'' (~70 kpc) diameter circle. We estimate the mass ratio between the two components to be between 1:1.25 and 1:1.58. In addition, spectroscopic data reveal that these two near-equal mass cores have only a small velocity difference of 300 km/s between the two components. This small radial velocity difference suggests that most of the relative velocity takes place in the plane of the sky, and implies that SPT-CL J0356-5337 is a major merger with a small impact parameter seen face-on. We also assess the relative contributions of galaxy-scale halos to the overall mass of the core of the cluster and find that within 800 kpc from the brightest cluster galaxy about 27% of the total mass can be attributed to visible and dark matter associated with galaxies, whereas only 73% of the total mass in the core comes from cluster-scale dark matter halos.Comment: 19 pages, 11 figures. Submitted to Ap

The use of laser in urogynaecology

Introduction The use of lasers in urogynaecology has increased in recent years. Their use has been described in pelvic organ prolapse, urinary incontinence and genito-urinary symptoms of menopause. The aim of this study was to review the published literature on CO2 and erbium:YAG laser use in urogynaecological conditions. Methods An extensive search of literature databases (PubMed, EMBASE) was performed for publications (full text and abstracts) written in English up to July 2018. Relevant trials were selected and analysed by an independent reviewer. Twenty-five studies were identified in total. Results All studies were either prospective cohort or case-control studies. The results of individual studies indicate that both CO2 and erbium lasers are effective in treating urogynaecological conditions. Most studies use a vaginal approach with only two investigations of intraurethral application. Conclusion The use of lasers to treat these conditions may seem appealing; however, the lack of good-quality evidence in the form of multi-centre randomised placebo-controlled trials is concerning. The safety and effectiveness of these laser devices have not been established. Use of lasers may lead to serious adverse events such as vaginal burns, scarring, dyspareunia and chronic pain. Randomised placebo-controlled trials in addition to formal evaluation of the laser devices are required before this treatment modality can be recommended

Silicone oil envelope for enhancing the performance of nanofluid-based direct absorption solar collectors

IIT Ropar; DST-SERB; Indo-US Science and Technology Forum (IUSSTF); Thapar Institute of Engineering & Technology, Patiala

The Expression of Inflammatory Mediators in Bladder Pain Syndrome.

Background: Bladder pain syndrome (BPS) pathology is poorly understood. Treatment strategies are empirical, with limited efficacy, and affected patients have diminished quality of life. Objective: We examined the hypothesis that inflammatory mediators within the bladder contribute to BPS pathology. Design, setting, and participants: Fifteen women with BPS and 15 women with stress urinary incontinence without bladder pain were recruited from Cork University Maternity Hospital from October 2011 to October 2012. During cystoscopy, 5-mm bladder biopsies were taken and processed for gene expression analysis. The effect of the identified genes was tested in laboratory animals. Outcome measures and statistical analysis: We studied the expression of 96 inflammation-related genes in diseased and healthy bladders. We measured the correlation between genes and patient clinical profiles using the Pearson correlation coefficient. Results and limitations: Analysis revealed 15 differentially expressed genes, confirmed in a replication study. FGF7 and CCL21 correlated significantly with clinical outcomes. Intravesical CCL21 instillation in rats caused increased bladder excitability and increased c-fos activity in spinal cord neurons. CCL21 atypical receptor knockout mice showed significantly more c-fos upon bladder stimulation with CCL21 than wild-type littermates. There was no change in FGF7-treated animals. The variability in patient samples presented as the main limitation. We used principal component analysis to identify similarities within the patient group. Conclusions: Our study identified two biologically relevant inflammatory mediators in BPS and demonstrated an increase in nociceptive signalling with CCL21. Manipulation of this ligand is a potential new therapeutic strategy for BPS. Patient summary: We compared gene expression in bladder biopsies of patients with bladder pain syndrome (BPS) and controls without pain and identified two genes that were increased in BPS patients and correlated with clinical profiles. We tested the effect of these genes in laboratory animals, confirming their role in bladder pain. Manipulating these genes in BPS is a potential treatment strategy

A Preliminary Analysis of Software Metrics in Decentralised Applications

This study examines software metrics in decentralized applications (dApps) to analyze their structural and behavioral characteristics as they grow in complexity. Sixty dApps were categorized into Small (3 to 29 contracts), Medium (30 to 46 contracts), and Large (47 to 206 contracts) based on their contract count. Initial analysis showed a non-normal data distribution, leading to the use of Spearman's correlation method. Findings revealed that Medium dApps have strong correlations between metrics like 'Average Local Variables' and 'Maximum Local Variables', while Large dApps show higher correlations between 'Number of Functions' and 'State Variable Count', indicating more complex contract structures. The higher Coupling Between Objects (CBO) in large dApps suggests increased interactions with other contracts or libraries, potentially elevating security risks. These insights are valuable for developers and stakeholders in the blockchain and IoT sectors, aiding in understanding how dApps evolve with increasing complexity and the implications on software metric relationships.Ethereum Foundation grant FY23-1048